Harrow, Inc.
HROW
#5428
Rank
A$2.03 B
Marketcap
A$54.67
Share price
-0.79%
Change (1 day)
52.15%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2025 (TTM): A$30.33 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are A$0.25 Billion. In 2024 the company made an earning of A$7.63 Million, an increase over its 2023 earnings that were of -A$3.34 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$30.33 M297.34%
2024 A$7.63 M-329.09%
2023 -A$3.34 Million-224.34%
2022 A$2.68 M3.01%
2021 A$2.6 M149.06%
2020 A$1.04 M434.29%
2019 A$0.19 M-102.68%
2018 -A$7.29 Million-57.11%
2017 -A$16.99 Million-21.93%
2016 -A$21.76 Million5.11%
2015 -A$20.71 Million46.16%
2014 -A$14.17 Million32.68%
2013 -A$10.68 Million42.63%
2012 -A$7.49 Million
2010 -A$3.46 Million-45.76%
2009 -A$6.38 Million21.83%
2008 -A$5.24 Million-491.97%
2007 A$1.33 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.23 Billion-902.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$25.36 Million-191.39%๐Ÿ‡บ๐Ÿ‡ธ USA